艾滋病毒感染女性对心脏健康和心血管风险以及干预偏好的了解
Lunthita M Duthely1,2, Sanjana Satish3, Sapna A Kedia3
1Department of Obstetrics, Gynecology & Reproductive Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
International journal of environmental research and public health
|September 28, 2024
概括
艾滋病毒感染女性患心血管疾病 (CVD) 风险较高. 了解耻辱和性对于为这一群体制定有效的心血管疾病预防策略至关重要.
科学领域:
- 公共卫生 公共卫生
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
背景情况:
- 心血管疾病 (CVD) 是一个主要的健康问题,具有复杂的决定因素.
- 与一般女性人口相比,艾滋病毒感染女性 (WWH) 的心脏病发病率较高.
- 耻辱和弹性越来越被认为是CVD发展和管理的重要因素.
研究的目的:
- 探索心血管疾病 (CVD) 风险因素和艾滋病毒感染妇女 (WWH) 的预防策略.
- 了解污名,弹性和心血管疾病风险在WWH中的相互作用.
- 确定知识差距和对WWH中心血管疾病风险降低干预措施的意愿.
主要方法:
- 对90分钟的焦点小组进行了定性分析,其中包括35岁以上的19名艾滋病毒感染女性 (WWH).
- 焦点小组旨在引起参与者对心血管疾病风险和潜在预防策略的了解.
- 在2022年5月收集的数据.
主要成果:
- 参与者报告说,他们从各种社会圈子中经历了与他们的艾滋病毒诊断相关的刻板印象.
- 生活事件引发了积极的生活方式变化和消极的健康行为.
- 100%的参与者表示愿意参与诸如药物治疗或生活方式改变等干预措施,尽管对心血管疾病有一些误解.
结论:
- 对于医疗保健提供者和患者来说,更深入地了解耻辱,弹性和心血管疾病之间的相互作用是必不可少的.
- 需要进行干预措施,以减少美国南部艾滋病毒感染的种族/少数民族妇女的心血管疾病风险.
- 解决知识差距和误解对于在WWH中有效预防心血管疾病至关重要.
相关概念视频
Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11
Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Heart Failure V: Nursing Interventions
2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Assessment of the Cardiovascular System I: Subjective Data
282
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320


